首页> 外文期刊>Biologicals: Journal of the International Association of Biological Standardization >A need for careful evaluation of endotoxin contents in acellular pertussis-based combination vaccines
【24h】

A need for careful evaluation of endotoxin contents in acellular pertussis-based combination vaccines

机译:需要仔细评估基于脱细胞百日咳的组合疫苗中内毒素的含量

获取原文
获取原文并翻译 | 示例
           

摘要

Two batches each of diphtheria-tetanus-acellular pertussis vaccine (DTaP) and that combined with inactivated polio vaccine purchased from foreign markets were tested by mouse body weight decreasing (BWD) toxicity test and Limulus amaebocyte lysate (LAL) test. Three out of the four imported vaccine batches showed the levels of BWD toxicity even comparable to that of DT-whole cell pertussis vaccine. BWD toxicity test is based on endotoxin dose-dependent weight loss of mice and has been used for controlling endotoxin in DTaP. Although of the strong BWD toxicity of the imported vaccines, there was no marked difference in LAL test results between the imported vaccines and Japanese DTaP. However, one imported DTaP batch showed very strong interference with LAL activity of spiked lipopolysaccharide (LPS). The batch interfered not only with LAL activity but also with pyrogenicity and prostaglandin E 2 induction activity. However, the pyrogenicity of the spiked LPS could be recovered from the precipitated fraction of the batch by treating with phosphate buffer to suggest the possibility of recovering invivo toxicity. As an adequate invitro test method could not be identified for controlling the safety of the interfering batch, an appropriate invivo test would be required for testing such vaccines.
机译:通过小鼠体重降低(BWD)毒性试验和Li变形细胞裂解液(LAL)试验分别测试了两批白喉破伤风无细胞百日咳疫苗(DTaP)以及与从国外市场购买的灭活脊髓灰质炎疫苗的组合。在四批进口疫苗中,三分之二的BWD毒性水平甚至与DT全细胞百日咳疫苗相当。 BWD毒性测试基于小鼠的内毒素剂量依赖性体重减轻,已用于控制DTaP中的内毒素。尽管进口疫苗具有强烈的BWD毒性,但进口疫苗与日本DTaP之间的LAL测试结果没有显着差异。但是,一批进口的DTaP批次对加标的脂多糖(LPS)的LAL活性表现出非常强烈的干扰。该批料不仅干扰LAL活性,而且干扰热原性和前列腺素E 2诱导活性。但是,加标的LPS的热原性可通过用磷酸盐缓冲液处理从批次的沉淀级分中回收,从而表明有可能恢复体内毒性。由于无法确定适当的体外测试方法来控制干扰批次的安全性,因此需要适当的体内测试来测试此类疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号